Conventional and assisted suicide in Switzerland: Insights into a divergent development based on cancer‐associated self‐initiated deaths
Cancer Medicine · 2023
DOI: 10.1002/cam4.6323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Uwe Güth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Brust-Zentrum Zürich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Suicide, Assisted, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
We tested the hypothesis of supporters of assisted dying that assisted suicide (AS) might be able to prevent cases of conventional suicide (CS).
Methods
By using data from the Federal Statistical Office, we analyzed the long‐term development of 30,756 self‐initiated deaths in Switzerland over a 20‐year period (1999–2018; CS: n = 22,018, AS: n = 8738), focusing on people suffering from cancer who died from AS or CS.
Results
While cancer was the most often listed principal disease for AS ( n = 3580, 41.0% of AS cases), cancer was listed in only a small minority of CS cases ( n = 832, 3.8% of CS cases). There was a significant increase in the absolute number of cancer‐associated AS cases: comparing four 5‐year periods, there was approximately a doubling of cases every 5 years (1999–2003: n = 228 vs.2004–2008: n = 474, +108% compared with the previous period; 2009–2013: n = 920, +94%; 2014–2018: n = 1958, +113%). The ratio of cancer‐associated AS in relationship with all cancer‐associated deaths increased over time to 2.3% in the last observation period (2014–2018). In parallel, the numbers of cancer‐associated CS showed a downward trend only at the beginning of the observation period (1999–2003, n = 240 vs. 2004–2008, n = 199, −17%). Thereafter, the number of cases remained stable in the subsequent 5‐year period (2009–2013, n = 187, −6%), and increased again toward the most recent period (2014–2018, n = 206, +10%).
Conclusion
The assumption that, with the increasingly accessible option of AS for patients with cancer, CS suicide will become “superfluous” cannot be confirmed. There are strong reasons indicating that situations and circumstances of cancer‐associated CS are different from those for cancer‐associated AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, Brust-Zentrum Zürich, Zurich, Switzerland.
- Faculty of Medicine, University of Basel, Basel, Switzerland.
- Federal Statistical Office, Neuchâtel, Switzerland.
- Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.
- Center for Legal Medicine, University of Geneva, Genève, Switzerland.
- Faculty of Medicine, University of Witten/Herdecke, Witten, Germany.
ORCID-Profile: Uwe Güth
Förderung
- NCI NIH HHS
Zitieren
APA
Güth, U., Junker, C., Elger, B. S., Elfgen, C., Montagna, G., & Schneeberger, A. R. (2023). Conventional and assisted suicide in Switzerland: Insights into a divergent development based on cancer‐associated self‐initiated deaths. Cancer Medicine. https://doi.org/10.1002/cam4.6323
Vancouver
Güth U, Junker C, Elger BS, Elfgen C, Montagna G, Schneeberger AR. Conventional and assisted suicide in Switzerland: Insights into a divergent development based on cancer‐associated self‐initiated deaths. Cancer Medicine. 2023. doi:10.1002/cam4.6323
BibTeX
@article{Gth2023,
author = {Güth, Uwe and Junker, Christoph and Elger, Bernice Simone and Elfgen, Constanze and Montagna, Giacomo and Schneeberger, Andres R},
title = {Conventional and assisted suicide in Switzerland: Insights into a divergent development based on cancer‐associated self‐initiated deaths},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6323}
}
EUVIMED